• 78 results in Exploration of Neuroprotective Therapy
    Sort by
    Latest
    Open Access
    Review
    Cerebral stroke-induced neurogenesis: insights and therapeutic implications
    Stroke, one of the leading causes of global morbidity and mortality, results from disrupted cerebral blood circulation, leads to cellular damage or death. Ischemic stroke, the predominant subtype, r [...] Read more.
    Mydhili Radhakrishnan ... Sumana Chakravarty
    Published: April 26, 2024 Explor Neuroprot Ther. 2024;4:172–197
    DOI: https://doi.org/10.37349/ent.2024.00078
    This article belongs to the special issue Intervention of Neuroimmune Responses
    View:381
    Download:27
    Times Cited: 0
    Open Access
    Original Article
    Lifetime stressors relate to invisible symptoms of multiple sclerosis
    Aim: Childhood stressors can increase adult stress perception and may accumulate over the lifespan to impact symptoms of multiple sclerosis (MS). Growing evidence links childhood stressors (e.g., [...] Read more.
    Carri S. Polick ... Sarah A. Stoddard
    Published: April 22, 2024 Explor Neuroprot Ther. 2024;4:158–171
    DOI: https://doi.org/10.37349/ent.2024.00077
    View:433
    Download:22
    Times Cited: 0
    Open Access
    Mini Review
    Neuronal plasticity in dorsal root ganglia following sciatic nerve injury
    It is widely known that each tissue has unique mechanisms to respond to injury and maintain homeostasis effectively. Although peripheral nerves have limited regeneration capacity, they conduct a com [...] Read more.
    Burcu Delibaş ... Süleyman Kaplan
    Published: April 17, 2024 Explor Neuroprot Ther. 2024;4:148–157
    DOI: https://doi.org/10.37349/ent.2024.00076
    This article belongs to the special issue Peripheral Nerve Regeneration
    View:327
    Download:26
    Times Cited: 0
    Open Access
    Review
    Biomarkers in neurodegenerative diseases: a broad overview
    Degeneration and dysfunction of neurons in the brain are hallmarks of neurodegenerative diseases. Over the past decades, significant efforts have been devoted to the development and validation of bi [...] Read more.
    Sathish Selvam, Velpandi Ayyavoo
    Published: April 16, 2024 Explor Neuroprot Ther. 2024;4:119–147
    DOI: https://doi.org/10.37349/ent.2024.00075
    This article belongs to the special issue The Future of Biomarkers in CNS Diseases
    View:972
    Download:33
    Times Cited: 0
    Open Access
    Perspective
    “Vitaction” deficiency: a possible root cause for multiple lifestyle disorders including Alzheimer’s disease
    Behavioural environment and behavioural responses of an individual are known to affect multiple aspects of physiology including neuroendocrine and growth factor signalling, angiogenesis, stem cell d [...] Read more.
    Milind Watve, Ashwini Keskar Sardeshmukh
    Published: April 07, 2024 Explor Neuroprot Ther. 2024;4:108–118
    DOI: https://doi.org/10.37349/ent.2024.00074
    This article belongs to the special issue The Urgent Need for New Hypotheses to Develop Effective Therapeutic Tools Against Alzheimer's Disease
    View:642
    Download:23
    Times Cited: 0
    Open Access
    Perspective
    Targeting short-chain fatty acids receptors signalling for neurological disorders treatment
    Short-chain fatty acids (SCFAs) play a key role regulating immune and metabolic homeostasis. Consequently, dysregulation in SCFA levels is involved in the pathogenesis of autoimmune, inflammatory, m [...] Read more.
    Carolina Prado, Rodrigo Pacheco
    Published: March 19, 2024 Explor Neuroprot Ther. 2024;4:100–107
    DOI: https://doi.org/10.37349/ent.2024.00073
    View:513
    Download:29
    Times Cited: 0
    Open Access
    Systematic Review
    Analysis of congenital Zika syndrome clinicopathologic findings reported in the 8 years since the Brazilian outbreak
    Aim: A Zika virus outbreak that began in Brazil, developed into an international public health emergency that extended from February 2015 until November 2016. Zika-infected pregnant women gave bi [...] Read more.
    Dhaara Shah ... Rana Zeine
    Published: February 27, 2024 Explor Neuroprot Ther. 2024;4:82–99
    DOI: https://doi.org/10.37349/ent.2024.00072
    This article belongs to the special issue Neuro-Inflammation as a Target in the Design of Multifunctional Drug Candidates for Neurodegenerative Diseases
    View:1245
    Download:31
    Times Cited: 0
    Open Access
    Review
    Carbon nanotubes as neuroprotective agents
    Carbon nanotubes, an emerging class of carbon nanomaterials, possess tremendous potential for application in biotechnology and biomedicine particularly in neurological disorders. Carbon nanotubes ow [...] Read more.
    Daisy L. Wilson ... Mahesh Narayan
    Published: February 27, 2024 Explor Neuroprot Ther. 2024;4:72–81
    DOI: https://doi.org/10.37349/ent.2024.00071
    This article belongs to the special issue Parkinson's Disease: Principal Targets and Interventional Mechanisms
    View:582
    Download:25
    Times Cited: 0
    Open Access
    Review
    Advances in neuroprotective therapy for acute ischemic stroke
    Acute ischemic stroke (AIS) is the leading cause of disability worldwide, and recanalization therapy is primary in the hyperacute phase of AIS. However, reperfusion injury and hemorrhagic transforma [...] Read more.
    Yang Yang ... Yi Li
    Published: February 27, 2024 Explor Neuroprot Ther. 2024;4:55–71
    DOI: https://doi.org/10.37349/ent.2024.00070
    This article belongs to the special issue Therapeutic Targets for Neuroprotection in Ischemic Stroke
    View:764
    Download:37
    Times Cited: 0
    Open Access
    Review
    The diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children
    Over the last two decades, immunoglobulin G (IgG) antibodies against myelin oligodendrocyte glycoprotein (MOG), previously thought to be a biomarker of multiple sclerosis (MS), have been shown to ca [...] Read more.
    Ünsal Yılmaz
    Published: February 27, 2024 Explor Neuroprot Ther. 2024;4:38–54
    DOI: https://doi.org/10.37349/ent.2024.00069
    This article belongs to the special issue The Future of Biomarkers in CNS Diseases
    View:593
    Download:27
    Times Cited: 0